שימוש במעכבי פרוטיאזום לטיפול בהפרעות בעדשת העין

• 收藏
• 分享

专利权人:

ACCUITIS PHARMACEUTICALS INC.

发明人:

申请号：

IL25915318

公开号：

IL259153D0

申请日:

2018.05.06

申请国别(地区):

IL

年份:

2018

代理人:

摘要：

Hydrocinnamate compounds that exhibit proteasome modulation activity, and in particular, proteasome inhibitory activity, can be used to topically or systemically treat ocular disorders associated with proteasome activity. The hydrocinnamate compounds can be applied to the eye, in any of a variety of ocular formulations, to treat ocular disorders, such as ocular rosacea, diabetic retinopathy, macular degeneration, and dry eye. The hydrocinnamate compounds can also be administered systemically to treat ocular disorders.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/